ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,995 | +3.2% | 1,329,741 | +9.3% | 0.00% | 0.0% |
| Q2 2023 | $1,934 | +137.3% | 1,216,641 | +7.0% | 0.00% | +200.0% |
| Q1 2023 | $815 | +30.8% | 1,136,741 | +5.8% | 0.00% | 0.0% |
| Q4 2022 | $623 | -99.9% | 1,074,241 | -4.0% | 0.00% | -50.0% |
| Q3 2022 | $1,063,000 | -19.0% | 1,118,441 | +2.3% | 0.00% | 0.0% |
| Q2 2022 | $1,312,000 | +152.8% | 1,093,041 | +175.7% | 0.00% | +100.0% |
| Q1 2022 | $519,000 | -53.9% | 396,441 | -38.1% | 0.00% | 0.0% |
| Q4 2021 | $1,127,000 | -53.1% | 640,177 | -42.2% | 0.00% | -66.7% |
| Q3 2021 | $2,402,000 | -15.2% | 1,106,777 | +36.8% | 0.00% | -25.0% |
| Q2 2021 | $2,832,000 | +126.9% | 809,280 | +539.4% | 0.00% | +100.0% |
| Q1 2021 | $1,248,000 | -72.2% | 126,577 | -71.0% | 0.00% | -50.0% |
| Q3 2020 | $4,497,000 | -63.1% | 436,588 | -25.1% | 0.00% | -63.6% |
| Q2 2020 | $12,172,000 | +14.9% | 582,948 | -46.2% | 0.01% | +10.0% |
| Q1 2020 | $10,592,000 | -36.8% | 1,084,148 | -25.5% | 0.01% | -23.1% |
| Q4 2019 | $16,771,000 | +14.3% | 1,455,848 | -45.9% | 0.01% | +8.3% |
| Q3 2019 | $14,677,000 | -68.0% | 2,693,000 | -30.2% | 0.01% | -70.0% |
| Q2 2019 | $45,866,000 | +130.7% | 3,857,500 | +1.7% | 0.04% | +122.2% |
| Q1 2019 | $19,882,000 | +69.8% | 3,794,300 | +2.1% | 0.02% | +38.5% |
| Q4 2018 | $11,711,000 | -45.4% | 3,717,767 | +4.9% | 0.01% | -40.9% |
| Q3 2018 | $21,432,000 | -45.9% | 3,542,500 | -50.2% | 0.02% | 0.0% |
| Q2 2018 | $39,597,000 | +83.0% | 7,119,177 | +90.8% | 0.02% | -8.3% |
| Q1 2018 | $21,643,000 | +142.1% | 3,731,577 | +46.1% | 0.02% | +140.0% |
| Q4 2017 | $8,941,000 | +33.1% | 2,554,677 | +38.8% | 0.01% | +25.0% |
| Q3 2017 | $6,718,000 | +88.7% | 1,840,470 | +29.3% | 0.01% | +60.0% |
| Q2 2017 | $3,560,000 | +15.5% | 1,423,940 | +24.7% | 0.01% | +25.0% |
| Q1 2017 | $3,083,000 | +9.6% | 1,141,977 | +17.8% | 0.00% | 0.0% |
| Q4 2016 | $2,812,000 | -31.9% | 969,700 | -3.5% | 0.00% | -42.9% |
| Q3 2016 | $4,128,000 | +77.7% | 1,004,400 | +36.6% | 0.01% | +75.0% |
| Q2 2016 | $2,323,000 | – | 735,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
| Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
| ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
| RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
| Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
| VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
| Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
| VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
| Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |